Results 161 to 170 of about 206,446 (295)

Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGFβ signaling in the mouse retina

, 2018
Ralph J. Hazlewood, Qingxia Chen, Frances K. Clark, John Kuchtey, Rachel W. Kuchtey   +4 more
openalex   +2 more sources

Inhibitory Effect of thePunica granatumFruit Extract on Angiotensin-II Type I Receptor and Thromboxane B2 in Endothelial Cells Induced by Plasma from Preeclamptic Patients [PDF]

, 2016
Widya Kusumawati, Kusnarman Keman, Setyawati Soeharto   +2 more
openalex   +1 more source

Molecular basis of domain-specific angiotensin I-converting enzyme inhibition by the antihypertensive drugs enalaprilat, ramiprilat, trandolaprilat, quinaprilat and perindoprilat. [PDF]

FEBS J
Gregory KS, Ramasamy V, Sturrock ED, Acharya KR.   +3 more
europepmc   +1 more source

Molecular docking and antihypertensive effects of a novel angiotensin-I converting enzyme inhibitory peptide from yak bone. [PDF]

Front Nutr, 2022
Gao X, Bu F, Yi D, Liu H, Hou Z, Zhang C, Wang C, Lin JM, Dang Y, Zhao Y.   +9 more
europepmc   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Ciprofloxacin Inhibits Angiotensin I‑Converting Enzyme (ACE) Activity by Binding at the Exosite, Distal to the Catalytic Pocket. [PDF]

ACS Bio Med Chem Au
Gregory KS, Ramasamy V, Sturrock ED, Acharya KR.   +3 more
europepmc   +1 more source

Production, identification, in silico analysis, and cytoprotection on H₂O₂-induced HUVECs of novel angiotensin-I-converting enzyme inhibitory peptides from Skipjack tuna roes. [PDF]

Front Nutr, 2023
Zhu WY, Wang YM, Ge MX, Wu HW, Zheng SL, Zheng HY, Wang B.   +6 more
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction.

, 1994
László Hunyady, Albert J. Baukal, Tamás Balla, Kevin Catt   +3 more
openalex   +1 more source

Investigation of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Germinated Lamtoro Gung Using <i>In Vitro</i> and <i>In Silico</i> Approaches. [PDF]

Prev Nutr Food Sci
Fitriani A, Indrati R, Marsono Y, Supriyadi S.   +3 more
europepmc   +1 more source